Author:
Mitin Timur,Shipley William U.,Efstathiou Jason A.,Heney Niall M.,Kaufman Donald S.,Lee Richard J.,Zietman Anthony L.
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349(9):859–66. Epub 2003/08/29.
2. Zehnder P, Studer UE, Skinner EC, Dorin RP, Cai J, Roth B, et al. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol. 2011;186(4):1261–8. Epub 2011/08/19.
3. Efstathiou JA, Quinn DI, Stenzl A, Bellmunt J, Cookson MS, Gakis G, et al. Radiation-based bladder preserving strategies: Radiation alone or combined with other modalities. In: Soloway MS, Khoury S, editors. Bladder Cancer: International Consultation on Bladder Cancer - Vienna, 2nd ed. Paris, France: Editions 21; 2012. p. 316-26.
4. •• Efstathiou JA, Spiegel DY, Shipley WU, Heney NM, Kaufman DS, Niemierko A, et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol. 2012;61(4):705–11. Epub 2011/11/22. This is a long-term (7.7 years) followup of 348 patients treated with bladder-preservation trimodality therapy that allays fears of significant rates of late tumor recurrences and of poor bladder function.
5. Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder. Eur Urol. 2013;63(1):45–57. doi: 10.1016/j.eururo.2012.08.061 .